4-Hydroxynonenal (HNE) is the most studied end product of the lipoperoxidation process, by virtue of its relevant biological activity. The antiproliferative and proapoptotic effects of HNE have been widely demonstrated in a great variety of tumor cell types in vitro. Thus, it might represent a promising new molecule in anticancer therapy strategies. However, the extreme reactivity of this aldehyde, as well as its insolubility in water, a limiting factor for drug bioavailability, and its rapid degradation by specific enzymes represent major obstacles to its possible in vivo application. Various strategies can used to overcome these problems. One of the most attractive strategies is the use of nanovehicles, because loading drugs into nanosized structures enhances their stability and solubility, thus improving their bioavailability and their antitumoral effectiveness. Several natural or synthetic polymers have been used to synthesize nanosized structures and, among them, β-cyclodextrin (βCD) polymers are playing a very important role in drug formulation by virtue of the ability of βCD to form inclusion compounds with a wide range of solid and liquid molecules by molecular complexation. Moreover, several βCD derivatives have been designed to improve their physicochemical properties and inclusion capacities. Here we report that the inclusion complex of HNE with a derivative of βCD, the βCD-poly(4-acryloylmorpholine) conjugate (PACM-βCD), enhances the aldehyde stability. Moreover, the inclusion of HNE in PACM-βCD potentiates its antitumor effects in several tumor cell lines and in a more complex system, such as a human reconstructed skin carrying melanoma tumor cells.

The inclusion complex of 4-hydroxynonenal with a polymeric derivative of Β-cyclodextrin enhances the antitumoralefficacyof the aldehyde in several tumor cell lines and in a three-dimensional human melanoma model

PIZZIMENTI, Stefania;CIAMPORCERO, ERIC STEFANO;PETTAZZONI, PIERGIORGIO;OSELLA ABATE, Simona;NOVELLI, Mauro;DAGA, MARTINA;MINELLI, ROSALBA;BISAZZA, AGNESE;BERNENGO, Maria Grazia;DIANZANI, Chiara;BIASI, Fiorella;CAVALLI, Roberta;BARRERA, Giuseppina
2013

Abstract

4-Hydroxynonenal (HNE) is the most studied end product of the lipoperoxidation process, by virtue of its relevant biological activity. The antiproliferative and proapoptotic effects of HNE have been widely demonstrated in a great variety of tumor cell types in vitro. Thus, it might represent a promising new molecule in anticancer therapy strategies. However, the extreme reactivity of this aldehyde, as well as its insolubility in water, a limiting factor for drug bioavailability, and its rapid degradation by specific enzymes represent major obstacles to its possible in vivo application. Various strategies can used to overcome these problems. One of the most attractive strategies is the use of nanovehicles, because loading drugs into nanosized structures enhances their stability and solubility, thus improving their bioavailability and their antitumoral effectiveness. Several natural or synthetic polymers have been used to synthesize nanosized structures and, among them, β-cyclodextrin (βCD) polymers are playing a very important role in drug formulation by virtue of the ability of βCD to form inclusion compounds with a wide range of solid and liquid molecules by molecular complexation. Moreover, several βCD derivatives have been designed to improve their physicochemical properties and inclusion capacities. Here we report that the inclusion complex of HNE with a derivative of βCD, the βCD-poly(4-acryloylmorpholine) conjugate (PACM-βCD), enhances the aldehyde stability. Moreover, the inclusion of HNE in PACM-βCD potentiates its antitumor effects in several tumor cell lines and in a more complex system, such as a human reconstructed skin carrying melanoma tumor cells.
65
765
777
4-hydroxynonenal; Bio-nanotechnology; Cyclodextrin derivatives; tumor cells; 3D model
Stefania Pizzimenti; Eric Ciamporcero; Piergiorgio Pettazzoni; Simona Osella-Abate; Mauro Novelli; Cristina Toaldo; Miriam Husse; Martina Daga; Rosalba Minelli; Agnese Bisazza; Elisabetta Ranucci; Maria Grazia Bernengo; Chiara Dianzani; Fiorella Biasi; Roberta Cavalli; Giuseppina Barrera
File in questo prodotto:
File Dimensione Formato  
2013 free rad biol med.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 5.89 MB
Formato Adobe PDF
5.89 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
2013 FREE RAD BIOL MED inclusione complex HNE_POST PRINT_4aperto.pdf

Accesso aperto

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 1.17 MB
Formato Adobe PDF
1.17 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/146395
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 12
social impact